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Epidemiology of Diabetes Mellitus among 193,435 Cats Attending
Primary-Care Veterinary Practices in England
D.G. O’Neill, R. Gostelow, C. Orme, D.B. Church, S.J.M. Niessen, K. Verheyen, and D.C. Brodbelt
Background: Diabetes mellitus (DM) is a common endocrine disease of cats. The prevalence of DM in cats in England is
not well-defined.
Hypothesis/Objectives: To estimate the prevalence and identify risk factors for DM in a large population of cats attending
primary-care practices.
Animals: A cohort of 193,563 cats in the VetCompass Programme attending 118 primary-care practices in England.
Methods: Cross-sectional analysis of cohort clinical data. Data were extracted covering September 1st 2009 and August
31st 2014. Period prevalence of DM was calculated. Associations between risk factors and DM were assessed using logistic
regression modelling.
Results: Of 1,128 DM cases were identified among 194,563 cats (period prevalence 0.58%; 95% confidence interval [CI]
0.54–0.61). Multivariable modelling indicated that Tonkinese (OR 4.1; 95% CI 1.8–9.6; P = .001), Norwegian Forest (odds
ratio [OR] 3.5; 95% CI 1.3–9.6; P = .001) and Burmese (OR 3.0; 95% CI 2.0–4.4; P < .001) cats had increased odds of DM
compared with crossbred cats. DM odds increased as bodyweight categories increased above 4 kg (P < .001), as cats aged
beyond 6 years old (P < .001) and in insured cats (OR 2.0; 95% CI 1.6–2.4; P < .001) but sex was not significantly associated
with DM.
Conclusions and Clinical Importance: Diabetes mellitus is an important component of the primary-care practice caseload
with 1-in-200 cats affected. An increased risk of DM in certain cat breeds supports a genetic predisposition. These results can
guide future research and preventative healthcare.
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Diabetes mellitus (DM) is one of the most commonendocrine diseases of cats, although prevalence
estimates have varied between studies that were based
on different patient populations and locations.1 The
only previous study to estimate the prevalence of DM
in UK cats reported a prevalence of 0.43% among an
insured population of 14,030 cats,2 whereas estimates
from university teaching hospitals range from 0.21% in
Sweden3 to 1.24% in the United States.4
The majority of cats with DM resemble Type 2 DM in
people, which originates from a combination of decreased
b-cell function, insulin resistance and contributing envi-
ronmental and genetic factors.1 However, DM in cats can
also result from other causes. Hypersomatotropism
(acromegaly) has been estimated to cause 25% of dia-
betes cases in cats in the United Kingdom,5 and other
recognized causes include hyperadrenocorticism,6 pancre-
atic disease7 and diabetogenic drug administration.8
Male sex has often been identified as a risk factor for
development of DM in the cat4,9,10 and DM in cats also
shares several predisposing factors with Type 2 DM in
people, including increasing age, physical inactivity
and obesity.9–11 In cats, obesity is proposed to cause
insulin resistance through various mechanisms, includ-
ing altered secretion of adipokine hormones and
changes in lipid metabolism.12,13 Not all obese or older
cats develop DM, however, so other genetic or environ-
mental factors might determine whether an individual
eventually becomes diabetic. Genetic research into DM
in cats is at a preliminary stage, whereas over 70 sus-
ceptibility genes have been identified for human Type 2
DM.14 Early work in cats has identified a single nucleo-
tide polymorphism in the melanocortin 4 receptor gene,
which is associated with the development of DM in
overweight domestic shorthair (DSH) cats15 and several
genetic loci associated with the development of DM in
lean DSH cats.16 However, it is probable that the heri-
tability of DM in cats is highly complex, as it is in
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people, and further investigation is required to clarify
the role that susceptibility genes might play in the devel-
opment of DM in cats.
A genetic component for DM in cats is also indicated
by specific feline breeds appearing to be at increased or
decreased risk of DM. Several studies have identified an
increased risk of DM in Burmese cats in the United
Kingdom, Europe, and Australia, and a recent Swedish
investigation demonstrated an increased risk in Norwe-
gian Forest cats, Russian Blues and Abyssinians, and a
decreased risk in Persians.2,17,18 An increased risk for
DM has not been documented in American Burmese
cats, which has been attributed to American Burmese
being genetically distinct from Burmese in other parts
of the world.19
The only previous study to investigate risk factors for
DM in cats in England analysed a modest-sized insured
population of 14,030 cats.2 However, a recent study esti-
mated that only 13.5% of cats in England are insured20
so the management of insured cats is unlikely to be repre-
sentative of the general owned feline population in Eng-
land. The aim of this study was to investigate the
prevalence of DM and to identify demographic risk fac-
tors for DM among a large cohort of cats attending pri-
mary-care practices in England. We hypothesized that
the Burmese and Norwegian Forest cat breeds have
increased risk of DM diagnosis compared with crossbred
cats.
Materials and Methods
The VetCompass Companion Animal Surveillance Programme21
collates de-identified electronic patient record (EPR) data from
primary-care veterinary practices in the United Kingdom for epi-
demiological research.22 Collaborating practices were selected
based on their willingness to participate and on the condition that
they recorded clinical data within an appropriately configured
practice management system (PMS). Practitioners recorded sum-
mary diagnosis terms from an embedded veterinary nomenclature
(VeNom)23 code list during episodes of clinical care. Collected
information related mainly to the owned feline population and
included patient demographic (species, breed, date of birth, sex,
insurance status and bodyweight) and clinical information (free-
form text clinical notes, summary diagnosis terms and treatment
with relevant dates) data fields. Electronic patient record data were
extracted from PMSs using integrated clinical queries22 and
uploaded to a secure VetCompass relational database. Ethical
approval of the project was granted by the Royal Veterinary Col-
lege Ethics and Welfare Committee (reference number 2014/S101).
The study design used a cross-sectional analysis of cohort clini-
cal data to estimate a period prevalence of DM and to evaluate
breed as a risk factor for DM. The study cohort comprised all cats
with at least 1 EPR (clinical note, VeNom summary diagnosis,
bodyweight or treatment) uploaded to the VetCompass database
from September 1st 2009 to August 31st 2014. The study inclusion
criterion for a DM case required the cat to have a final diagnosis
of DM (or synonym) recorded in the EPR. Once the study cohort
had been defined, all study cats were followed over the study per-
iod from September 1st 2009 to August 31st 2014 and any cat that
met the study inclusion criterion for a DM case at any time during
the study period was included as a case. All remaining cats in the
study cohort that were not identified as DM cases were included
in the analysis as noncases. When identifying breeds at increased
risk of DM, sample size calculations using Epi Info 7a estimated a
cross-sectional study would require 1,359 cats of each individual
breed being assessed and 135,827 crossbred cats to detect an odds
ratio of 2.0 or greater assuming a 0.6% DM prevalence in cross-
bred cats.
To identify DM cases from the EPRs, all cats in the eligible
study population were screened for candidate DM cases by search-
ing the clinical free-text field (multiple search terms: dm, diab, mel-
litus, DKA, ketoacid, hyperglyc, glucosur, ketonur), the VeNom
term fields (diabetes mellitus), and the treatment field (multiple
drug searches: insul, insuv, glargine, prozinc, pzi, diab). The results
from these searches were combined and randomized using the
RAND function in Microsoft Excelb to avoid any temporal bias
during further evaluation and data extraction because the patient
identification number depended on the date of the first EPR entry.
The full clinical notes of all candidate DM cases were manually
reviewed to confirm the presence of a final diagnosis of DM to
decide on case inclusion. For cats confirmed as DM cases, addi-
tional data were extracted from the EPR that described whether
the case was pre-existing (first diagnosed prior to September 1st
2009) or incident (first diagnosed during the study period from
September 1st 2009 to August 31st 2014), date of diagnosis for
incident cases and the date and mechanism of any deaths.
A binary purebred variable was used to group all cats recorded
with a breed name recognized by International Cat Care24 as
“purebred”, and all other cats as “crossbred”. A breed variable
comprised all individual breeds with 300 or more animals in the
overall study dataset, a grouping of all remaining purebred cats
and a grouping of crossbred cats. Insurance status described
whether a cat was insured at any point during the study period
and was included as a proxy indicator for both the human-animal
bond and the restriction of financial constraints on clinical care.25
The age values were calculated using the date of first diagnosis for
incident DM cases and the mid-point date between the first and
final EPRs for the noncases (termed EPR mid-point age). Pre-
existing DM cases were included in risk factor analysis as “age not
recorded” so the risk factor results could be interpreted as showing
the odds at each age group for “becoming a case” rather than for
“being a case”. Age (years) was categorized into 7 groups (<3.0,
3.0–5.9, 6.0–8.9, 9.0–11.9, 12–14.9, ≥15.0, not recorded). Body-
weight referred to the maximum bodyweight recorded for cats
older than 6 months and was categorized into 8 groups (0.0–
2.9 kg, 3.0–3.9 kg, 4.0–4.9 kg, 5.0–5.9, 6.0–6.9, 7.0–7.9, ≥8.0 kg,
not recorded). The time contributed to the study for each cat
described the period from the dates of the earliest to the latest
EPR and gave an indication of the underlying period upon which
the period prevalence values were dependent.
After data checking and cleaning in Microsoft Excelb, analyses
were conducted using Stata 13.c A period prevalence with 95%
confidence intervals (CI) for DM was reported that described the
prevalence of DM (including pre-existing and incident cases) over-
all and by breed. The CI estimates were derived from standard
errors based on approximation to the normal distribution.26
Descriptive statistics characterized purebred, breed, sex, insurance,
age, bodyweight, and time contributed to the study for the case
and noncase cats. Mortality data were summarized for the DM
cases alone. The Mann–Whitney U test was used to compare
bodyweight values between male and female cats.26
Binary logistic regression modeling was used to evaluate uni-
variable associations between risk factors (purebred, breed, body-
weight category, age category, sex, and insurance) and DM. Both
pre-existing and incident DM cases were included in risk factor
analysis. Risk factors with liberal associations in univariable
modeling (P < .2) were taken forward for multivariable evalua-
tion. Collinearity was assessed between all variables taken for-
ward for multivariable modeling using the Stata corr and collin
commands.27 Model development used manual backwards stepwise
elimination. To deal with complete separation of data for some
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breeds that had zero-cells (ie, a breed with no DM cases), the
Stata firthlogit programb allowed inference based on the profile
penalized likelihood.28 Clinic attended was parameterized as a ran-
dom effect and pair-wise interaction effects were evaluated for the
final model.29 The area under the ROC curve was used to evaluate
the discriminatory ability of the model to predict DM-positive and
DM-negative cats (nonrandom effect model).29 Statistical signifi-
cance was set at P < .05.
Results
The overall dataset comprised 194,563 cats attending
118 clinics in England between 1st September 2009 and
31st August 2014. The search strategies for possible
DM cases revealed 4,031 candidate animals. After man-
ual verification, 1,128 cats met the study inclusion crite-
rion for DM, yielding an apparent prevalence of 0.58%
(95% CI: 0.54–0.61%) for DM in cats attending pri-
mary-care veterinary practices in England. Of these DM
cases, 504 (44.7%) were pre-existing and 624 (55.3%)
were incident cases. The median time contributed to the
study across all cats in the dataset was 0.3 years (in-
terquartile range [IQR]: 0.0–1.8 years, range 0.0–
5.0 years). Breeds with the highest prevalence of DM
within-breed included the Burmese (2.27%, 95% CI
1.63–3.06), Norwegian Forest Cat (2.21%, 95% CI
0.96–4.31) and Tonkinese (2.17%, 95% CI 0.88–4.41),
while the prevalence in crossbred cats was 0.58% (95%
CI 0.54–0.61) (Table 1).
Completeness of data varied between the factors
assessed: breed 99.9%, sex 99.1%, insurance 55.9%, age
99.5%, and bodyweight 70.8%. Of the DM cats with
information available, 121 (10.7%) were purebred, 674
(59.8%) were male and 360 (41.6%) were insured.
Median bodyweight was 5.4 kg (IQR: 4.5–6.5, range
2.3–22.9) and the median age at diagnosis for incident
cases was 13.0 years (IQR: 10.3–15.0, range 1.0–21.8)
(Fig 1). The most commonly affected breeds overall
were crossbred cats (n = 1,006, proportion of case cats
89.2%), Burmese (n = 41, 3.6%), British Shorthair
(n = 9, 0.8%), Siamese (n = 9, 0.8%) and Norwegian
Forest cats (n = 8, 0.7%) (Table 2).
Of the noncase cats with information available,
20,709 (10.7%) were purebred, 93,333 (48.3%) were
male and 29,253 (27.1%) were insured. Median body-
weight was 4.2 (IQR: 3.5–5.1) kg and the median EPR
mid-point age was 4.1 (IQR: 1.2–10.2) years. The most
common breeds among the noncase cats were cross-
breds, British shorthair, Persian, Bengal, and Siamese
(Table 2).
There were 301 (48.3%) deaths among the 624 inci-
dent DM cases during the 5-year study period. Of the
291 deceased cats with a recorded mechanism of death,
270 (92.8%) of the deaths were assisted (euthanasia),
with the remaining 21 (7.2%) being unassisted. The
median age at death for 298 incident DM cases with
information available was 14.1 (IQR 11.5–16.3, range
1.0–21.5) years. Of the 301 cats that died during the
study period, 220 (73.1%) died within 1 year from the
date of diagnosis, 50 (16.6%) died between 1 and
2 years later, 25 (8.3%) died between 2 and 3 years
later and 6 (2.0%) died after 3 years. In the overall
study population, the median bodyweight of male cats
(4.8 kg, IQR 4.0–5.6) was higher than for female cats
(3.8 kg, IQR 3.1–4.5) (P < .001).
Univariable logistic regression modeling identified five
variables with liberally significant (P < .20) association
with DM diagnosis: breed, bodyweight, age, sex, and
insurance status (Table 2) which were further evaluated
using multivariable regression modeling. The final mul-
tivariable model (Table 3) retained four significant risk
factors (breed, bodyweight, age, and insurance status)
and showed good discrimination (area under the ROC
curve: 0.944). No biologically significant interactions
were identified. Including the clinic attended as a ran-
dom effect improved the final model (P < .001); the
clinic attended accounted for 4.2% of the variation in
the data. After accounting for the effects of the other
variables in the model, 3 breeds showed increased odds
of DM diagnosis compared with the crossbred cats:
Tonkinese (odds ratio [OR] 4.1; 95% CI 1.8–9.6;
P = .001), Norwegian Forest (OR 3.5; 95% CI 1.3–9.6;
P = .001) and Burmese (OR 3.0; 95% CI 2.0–4.4;
P < .001). Odds of DM increased as maximum recorded
bodyweight increased. Compared with cats weighing
under 3 kg, cats weighing 4.0–4.9 kg had 3.2 times the
odds (95% CI 2.0–5.2, P < .001) and cats weighing 5.0–
5.9 kg had 5.1 times the odds (95% CI 3.1–8.2,
P < .001) of DM. Increasing age was associated with
increasing odds of DM diagnosis; cats aged 6.0–
8.9 years showed 5.6 times the odds (95% CI 3.1–10.0,
P < .001) and cats aged 9.0–11.9 years showed 17.1
(95% CI 9.9–29.6, P < .001) times the odds of DM
diagnosis compared with cats aged 3.0–5.9 years.
Insured cats had 2.0 (95% CI 1.6–2.4, P < .001) times
Table 1. Prevalence of diabetes mellitus diagnosed
across cat breeds attending primary-care veterinary










Burmese 1810 41 2.27 1.63–3.06
Norwegian
Forest
362 8 2.21 0.96–4.31
Tonkinese 323 7 2.17 0.88–4.41
Oriental 312 3 0.96 0.20–2.78
Russian 428 4 0.93 0.26–2.38
Crossbred 173,578 1006 0.58 0.54–0.61
Maine Coon 1259 7 0.56 0.22–1.14
Rex 355 2 0.56 0.07–2.02
Siamese 1826 9 0.49 0.23–0.93
Other breed-types 2737 13 0.47 0.25–0.81
Persian 2465 7 0.28 0.11–0.58
Birman 1103 3 0.27 0.06–0.79
British short hair 3804 9 0.24 0.11–0.45
Bengal 2110 5 0.24 0.08–0.55
Ragdoll 1692 4 0.24 0.06–0.60
Exotic 399 0 0 0.0–0.92
Overall 194,563 1128 0.58 0.54–0.61
DM, diabetes mellitus; 95% CI, 95% confidence interval.
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the odds of DM diagnosis compared with uninsured
cats. Sex was not significantly associated with the odds
of DM in the final multivariable model.
Discussion
This study used the largest primary-care population
of cats in England assembled to date to report the
prevalence and risk factors for DM in cats. Our results
reaffirm DM as a relatively common condition diag-
nosed in UK primary-care practice; the 0.58% preva-
lence of DM recorded in this study is similar, although
slightly higher, than previous prevalence estimates from
insured feline populations in the United Kingdom
(0.43%)2 and from veterinary hospital populations in
the United States (0.42%)4 and slightly lower than esti-
mates in Australia (0.74%).18 The study identified an
increased risk of DM in Norwegian Forest, Burmese,
and Tonkinese cats compared with crossbred cats. A
greater risk of DM was also identified with increasing
age and bodyweight, and among insured cats.
The findings of this investigation support several pre-
vious studies that revealed an increased risk of DM in
Burmese cats30 and a recent study that identified
increased risk in Norwegian Forest Cats.17 However,
this is the first study to identify an increased risk of
DM in Tonkinese cats and these results are informative
in that breeds with a high within-breed prevalence but
that are not common in the general population, such as
the Tonkinese, may be overlooked without access to
large merged datasets such as the VetCompass data-
base. The Tonkinese breed was created in the 1950s
through cross-breeding of Burmese and Siamese cats.
This makes the Tonkinese and Burmese cat breeds
genetically similar and it is possible that this genetic
similarity could contribute to a shared predisposition
for DM.31 A genetic component to DM in Burmese cats
could also be supported by the increased DM risk
shown for Australian and European Burmese, whereas
an increased risk has not yet been demonstrated in the
genetically distinct American Burmese population.2,18,19
However, it should be noted that, although several
studies have investigated breed predispositions for DM
in North American cats,4,9 none of these have specifi-
cally assessed the Burmese breed. It is likely that genetic
predisposition for DM among cats is polygenic in ori-
gin, as it is people with Type 2 DM.14 Genetic studies
into human Type 2 DM have identified a large number
of susceptibility loci, many of which are thought to
increase a patient’s risk of developing DM by altering
b-cell function or insulin sensitivity in body tissues.32
Cats and people with insulin resistance can maintain
normoglycemia through a compensatory increase in
b-cell mass and insulin secretion, but will eventually
develop DM if this hypersecretory response fails.33–35 In
cats, insulin hypersecretion can be accompanied by
hyperamylinemia and it is thought that amyloid depo-
sition within pancreatic islets contributes to eventual
b-cell failure in DM in cats.36 However, in vitro and
rodent models have shown that even mild increases in
blood glucose concentration can lead to altered gene
expression in pancreatic b-cells and this is thought to
contribute to eventual b-cell failure in Type 2 diabetic
people.34,37 Genotype is therefore an important deter-
minant of a patient’s ability to withstand insulin resis-
tance, and their susceptibility to b-cell failure. Initial
work in cats with DM has identified a number of
genetic loci associated with DM development, includ-
ing several loci associated with DM in lean DSH
cats16 and a genetic polymorphism in the melanocortin
4 receptor, which is associated with DM in obese
domestic shorthair cats.15 This initial work supports
Fig 1. Ages of cats without (DM noncase; n = 192,505) and with (DM case; n = 621) diabetes mellitus attending primary-care veterinary
practices in England. The age was calculated for the DM noncases at the center-date of the available clinical records and for the DM cases
was at the date of first diagnosis.
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genotype in cats as an influence on DM susceptibility,
and may explain why certain purebred cat breeds show
increased, or decreased, risk of DM compared with
crossbred cats.
This study revealed progressively increasing risk of
DM as adult bodyweight increased above 2.9 kg.
Although body weight and body condition are not syn-
onymous, the increased risk of DM shown by the high-
est weight categories in this study could be partially
caused by the presence of overweight and obese cats in
these groups. Obesity is a well-recognized risk factor for
insulin resistance and DM in both cats and humans.38,39
Chronic adipose tissue inflammation is a major cause of
insulin resistance in obese people, but has not been doc-
umented in obese cats.13,38 However, other mechanisms
for obesity-related insulin resistance might be similar
between humans and cats. Derangements in the produc-
tion of adipokine hormones have been documented in
both obese cats and obese people. Adiponectin is a
prevalent adipokine that has insulin-sensitising and
anti-inflammatory properties. Reduced adiponectin con-
centrations have been demonstrated in obese people
and obese cats, and are associated with increased risk
of DM in people.40–42 In both humans and cats, obesity
is also associated with increased concentrations of the
adipokine leptin, which promotes energy utilization,
Table 2. Descriptive and univariable logistic regression results for risk factors associated with presence of diabetes
mellitus in cats attending primary-care veterinary practices in England. Data on both pre-existing and incident DM
cases were included.
Variable Category Case No. (%) Noncase No. (%) Odds Ratio 95% CI P-Value
Purebred status Crossbred 1006 (89.2) 172,572 (89.2) Base
Purebred 121 (10.7) 20,709 (10.7) 1.0 0.8–1.2 .98
Not recorded 1 (0.1) 154 (0.1) 1.1 0.2–8.0 .91
Breed Crossbred 1006 (89.2) 172,572 (89.2) Base
Tonkinese 7 (0.6) 316 (0.2) 3.8 1.8–8.1 <.001
Norwegian Forest 8 (0.7) 354 (0.2) 3.9 1.9–7.8 <.001
Burmese 41 (3.6) 1769 (0.9) 4.0 2.9–5.5 <.001
Russian 4 (0.4) 424 (0.22) 1.6 0.6–4.3 .34
Oriental 3 (0.3) 309 (0.2) 1.7 0.5–5.2 .38
Rex 2 (0.2) 353 (0.2) 1.0 0.2–3.9 .97
Siamese 9 (0.8) 1817 (0.9) 0.8 0.4–1.6 .63
Maine Coon 7 (0.6) 1252 (0.7) 1.0 0.5–2.0 .91
Birman 3 (0.3) 1100 (0.6) 0.5 0.2–1.5 .19
Persian 7 (0.6) 2458 (1.3) 0.5 0.2–1.0 .059
British Shorthair 9 (0.8) 3795 (2.0) 0.4 0.2–0.8 .007
Ragdoll 4 (0.4) 1688 (0.9) 0.4 0.2–1.1 .073
Bengal 5 (0.4) 2105 (1.1) 0.4 0.2–1.0 .045
Exotic 0 (0.0) 399 (0.2) 0.2 0.0–3.4 .28
Other breed-types 13 (1.2) 2724 (1.4) 0.8 0.5–1.4 .478
Bodyweight (kg) <3.0 28 (2.5) 16,681 (8.6) Base
3.0–3.9 118 (10.5) 39,938 (20.7) 1.8 1.2–2.7 .007
4.0–4.9 273 (24.2) 42,249 (21.8) 3.8 2.6–5.7 <.001
5.0–5.9 257 (22.8) 24,790 (12.8) 6.2 4.2–9.1 <.001
6.0–6.9 189 (16.8) 9317 (4.8) 12.1 8.1–18.0 <.001
7.0–7.9 118 (10.5) 2664 (1.4) 26.4 17.4–39.9 <.001
≥8.0 56 (5.0) 1029 (0.5) 32.4 20.5–51.3 <.001
No bodyweight available
for >6 month of age
89 (7.9) 56,767 (29.4) 0.9 0.6–1.4 .75
Age (years)a <3.0 6 (0.5) 81,075 (41.9) 0.2 0.1–0.4 <.001
3.0–5.9 14 (1.2) 32,034 (16.6) Base
6.0–8.9 66 (5.9) 22,330 (11.5) 6.8 3.8–12.0 <.001
9.0–11.9 154 (13.7) 18,892 (9.8) 18.7 10.8–32.2 <.001
12.0–14.9 222 (19.7) 18,422 (9.5) 27.6 16.1–47.3 <.001
≥15.0 159 (14.1) 19,752 (10.2) 18.4 10.7–31.8 <.001
Not recorded 507 (45.0) 930 (0.5) 1247.4 730.6–2129.9 <.001
Sex Female 450 (39.9) 98,436 (50.9) Base
Male 674 (59.8) 93,333 (48 3) 1.6 1.4–1.8 <.001
Not recorded 4 (0.4) 1666 (0.9) 0.5 0.2–1.4 .20
Insurance status Noninsured 506 (44.9) 78,642 (40.7) Base
Insured 360 (31.9) 29,253 (15.1) 1.9 1.7–2.2 <.001
Not recorded 262 (23.2) 85,540 (44.2) 0.5 0.4–0.6 <.001
95% CI, 95% confidence interval; EPR, electronic patient record.
aIncident cases: age at diagnosis, pre-existing cases: no age included, noncases: age at mid-point of clinical records.
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satiety, and decreased serum glucose concentrations.13,43
It is thought that hyperleptinemia in obese people
develops in response to “leptin resistance” in which
patients have an impaired biological response to leptin,
and a similar reduced response to leptin may therefore
contribute to insulin resistance in obese cats.44 Obesity
is also associated with dyslipidemia in both cats and
people.45,46 Increased concentrations of lipid metabolites
can contribute to insulin resistance by impairing insulin
signaling and inducing production of inflammatory
mediators.47 Previous work has shown that plasma pro-
files of lean Burmese cats show similar adipokine and
lipid abnormalities to those shown by obese DSH cats
suggesting that lean Burmese cats are in a metabolic
state that resembles naturally occurring obesity in
cats.45
Inclusion of cats with hypersomatotropism (acrome-
galy) in the diabetic group could also contribute to
the increased risk of DM identified with increasing
bodyweight category. Nearly 25% of DM cases in
cats in the United Kingdom have been estimated to
be caused by hypersomatotropism, so it is likely that
a substantial proportion of diabetic cases in the cur-
rent study were also affected by this condition.5
Acromegalic cats can show progressive weight gain
and have higher bodyweights than nonacromegalic
diabetic cats so their presence could have contributed
to the increased risk of DM seen with increasing
bodyweight in this study.5 Information on whether
diabetic cats received screening for acromegaly was
unfortunately not available for the current investiga-
tion. Finally, it is also possible that the increased risk
of DM in higher weight categories in this study might
reflect the influence of other factors that affect body-
weight, such as patient age and breed. Future studies
which extract data on body condition score as well as
bodyweight will help to disentangle these various
effects.
Table 3. Final multivariable logistic regression model for risk factors associated with diabetes mellitus diagnosis in
cats attending primary-care veterinary practices in England. Data on both pre-existing and incident DM cases were
included.
Variable Category OR 95% CI P-Value
Breed Crossbred Base
Tonkinese 4.1 1.8–9.6 .001
Norwegian Forest 3.5 1.3–9.6 .016
Burmese 3.0 2.0–4.4 <.001
Russian 2.5 0.8–8.1 .12
Oriental 1.8 0.4–7.3 .43
Rex 1.2 0.2–8.5 .88
Siamese 1.1 0.5–2.3 .77
Maine Coon 0.9 0.4–2.1 .74
Birman 0.8 0.3–2.6 .73
Persian 0.5 0.2–1.4 .20
British Short Hair 0.5 0.2–1.1 .080
Ragdoll 0.4 0.1–2.2 .31
Bengal 0.3 0.1–1.3 .11
Exotic 0.8 0.1–13.7 .91
Other breed-types 0.6 0.3–1.1 .11
Bodyweight (kg) <3.0 Base
3.0–3.9 1.4 0.8–2.3 .19
4.0–4.9 3.2 2.0–5.2 <.001
5.0–5.9 5.1 3.1–8.2 <.001
6.0–6.9 10.2 6.3–16.8 <.001
7.0–7.9 19.3 11.5–32.6 <.001
> or =8 20.0 11.0–36.3 <.001
No bodyweight available
for >6 month of age
0.0 0.0–0.1 <.001
Age (years)a <3.0 0.4 0.2–1.0 .060
3.0–5.9 Base
6.0 to <9.0 5.6 3.1–10.0 <.001
9.0 to <12.0 17.1 9.9–29.6 <.001
12.0 to <15.0 31.8 18.5–54.7 <.001
> or =15.0 39.1 22.5–67.9 <.001
No age available 59093.7 29330.8–119058.1 <.001
Insurance status Noninsured Base
Insured 2.0 1.6–2.4 <.001
Unknown 1.0 0.8–1.2 .90
95% CI, confidence interval.
aIncident cases: age at diagnosis, pre-existing cases: no age included, noncases: age at mid-point of clinical records.
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The study identified an increasing risk of DM as
patient age increased above 6 years. This finding agrees
with other studies showing increased risk of DM in
middle-aged to geriatric cats4,17 and resembles how
prevalence of Type 2 DM increases with age in human
patients.48 In people, an age-related decline in insulin
sensitivity and b-cell function are thought to contribute
to the increased risk of DM in older patients49 and sim-
ilar mechanisms might contribute to DM in cats. Aging
may also allow more time for significant amyloid depo-
sition in the pancreas of cats and this could contribute
to the development of DM in some cats.50 Finally,
many comorbid diseases that promote DM in cats, such
as hypersomatotropism and, admittedly more rarely,
hyperadrenocorticism, typically affect middle-aged or
older cats and thus increase risk of DM in these age
groups.5,6
Our study showed that 48% of incident diabetic cases
died or were euthanized during the study period with
the highest proportion of these deaths occurring within
1 year of diagnosis. This result is similar to the 1-year
mortality rate of 41% in diabetic cats examined at
Swiss and American referral hospitals51,52 but is lower
than the 1-year mortality rate of 68% found by a small
UK study that examined a primary-practice popula-
tion.54 Data on cause of death or reason for euthanasia
was not available for cats in our study, but previous
reports have found that concurrent diseases, rather than
DM itself, are the most common cause of mortality in
diabetic cats.53,54 However, the emotional, time, and
financial demands of managing a diabetic cat can be
high for some pet owners and trigger a decision to euth-
anize their pet.55
Insured cats showed twice the odds of DM diagnosis
compared with noninsure cats in this study. This may
partially reflect that insured cats may have more
bonded owners and are more likely to undergo investi-
gations and have DM diagnosed.56 However, animals
with health problems, such as DM, might be more
likely to have their insurance status recorded, which
could bias the study results toward detecting an
increased association between insurance and DM
diagnosis.
Although male cats showed 1.6 times the odds of
DM compared with female cats in the univariable anal-
ysis of the current study, sex did not significantly con-
tribute to a patient’s risk of DM after accounting for
the effects of other risk factors, including bodyweight in
the multivariable analysis. In contrast, many previous
studies that reported an increased risk of DM in male
cats.2,10 Male cats are more prone to obesity, than
female cats57 and some studies have also reported that
male cats are more likely to develop hypersoma-
totropism, which can cause DM alongside increasing
bodyweight.58 Several previous studies that reported
increased risk for DM in males did not have access to
detailed individual bodyweight data2,17 or did not adjust
for other confounding effects, such as bodyweight, when
assessing sex as a risk factor for DM.9,10 The current
study revealed no association between sex and DM; this
may have been because a substantial proportion of the
male risk was explained by the significantly greater
median bodyweight of males (4.8 kg) compared with
females (3.8 kg) in the study. It is also possible that any
remaining association between sex and risk of DM was
only weak and that the current study had insufficient
power to detect this.
This study had some limitations. Several previous
studies have examined neuter status as a risk factor for
DM.2,9 However, this was not evaluated in the current
study because the vast majority of study cats were neu-
tered early in life and neuter status would therefore
mainly reflect patient age. The median time contributed
to the study by each cat was short (0.3 years) but this
was a conservative estimate that covered just the period
between the first and final EPRs and did not also
account for the phases both before and after these
records when cats may also have presented to the vet-
erinary practices had they been ill. Electronic clinical
records are not primarily recorded for research purposes
and therefore may vary in quality across the participat-
ing practices.59 Classification of cases as diabetic relied
greatly on the clinical acumen and resources of the
participating veterinarians. Information on how individ-
ual DM cases were diagnosed, and what treatment
was given was not included in the current study but
will be explored in a follow-on study. Insurance status
described whether an animal was insured at any point
during the study period and it was possible that some
cats became insured following the initial DM diagnosis.
Finally, the practices that contributed to this study were
all private, primary-care practices mainly based in cen-
tral and south-eastern England and it is possible that
the patient population at charity clinics or practices
based elsewhere in the country might differ in their
management from the population represented in the
current study. This may affect generalizability of the
descriptive prevalence results which are more heavily
dependent on prevailing levels of clinical care but
should have had minimal impact on the risk factor
results which are more dependent on basic physiology
which will be more constant across all cats in
England.60
In conclusion, the findings of this investigation con-
firm that DM is a relatively common disease among
cats in England and is associated with high mortality.
The investigation supports previously identified risk
factors for DM in cats, including a greater risk with
increasing age and bodyweight, and an increased risk
in Burmese and Norwegian Forest cats. However, the
study is the first to report an increased risk of DM in
Tonkinese cats, which are derived from the Burmese
breed. This finding supports the theory that a genetic
component contributes to increased susceptibility for
DM in Burmese cats and related breeds. After
accounting for bodyweight and other risk factors,
male gender was not confirmed as a significant inde-
pendent risk factor. Findings from this study can
improve understanding of DM and diagnosis rates for
this disease, and improve welfare in cats by alerting
clinicians to demographic subsets of cats at increased
risk.
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